comparemela.com

Latest Breaking News On - Neogenomics company profile - Page 1 : comparemela.com

NeoGenomics (NASDAQ:NEO) Trading Up 8.8%

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report)’s share price rose 8.8% during trading on Wednesday . The company traded as high as $14.37 and last traded at $14.32. Approximately 505,729 shares changed hands during trading, a decline of 41% from the average daily volume of 858,388 shares. The stock had previously closed at $13.16. Analyst […]

United-kingdom
United-states
William-blair
Craig-hallum
Schroder-investment-management-group
Redwood-investments
Nasdaq
Goldman-sachs-group
Norges-bank
Neogenomics-inc
Neogenomics-company-profile
Legato-capital-management

Mckinley Capital Management LLC Has $2.97 Million Holdings in NeoGenomics, Inc. (NASDAQ:NEO)

Mckinley Capital Management LLC increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 32.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 183,610 shares of the medical research company’s stock after acquiring an additional 45,260 shares during the period. Mckinley […]

United-states
United-kingdom
Piper-sandler
William-blair
Clinical-services
Nasdaq
Needham-company
Quadrant-capital-group
Neogenomics-inc
Dimensional-fund-advisors
Asset-management-united-kingdom-ltd
Mitsubishi-ufj

Handelsbanken Fonder AB Has $322,000 Stock Position in NeoGenomics, Inc. (NASDAQ:NEO)

Handelsbanken Fonder AB lifted its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 7.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,900 shares of the medical research company’s stock after acquiring an additional 1,300 shares during the period. Handelsbanken Fonder AB’s holdings in NeoGenomics were worth $322,000 as of […]

United-kingdom
United-states
Alger
Algeria
Piper-sandler
Aliciac-olivo
Jennison-associates
Securities-exchange-commission
Neogenomics-company-profile
Nasdaq
Clinical-services
Goldman-sachs-group

NeoGenomics (NASDAQ:NEO) Stock Rating Reaffirmed by Benchmark

Benchmark reaffirmed their buy rating on shares of NeoGenomics (NASDAQ:NEO – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has a $18.00 price objective on the medical research company’s stock. Other research analysts also recently issued reports about the company. William Blair restated an outperform rating […]

United-kingdom
United-states
William-blair
Piper-sandler
Aliciac-olivo
Craig-hallum
Neogenomics-company-profile
Securities-exchange-commission
Financial-services-group-inc
Needham-company
Clinical-services
Goldman-sachs-group

NeoGenomics (NASDAQ:NEO) Research Coverage Started at Craig Hallum

NeoGenomics (NASDAQ:NEO) Research Coverage Started at Craig Hallum
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
Aliciac-olivo
Banque-cantonale-vaudoise
Piper-sandler
William-blair
Craig-hallum
Needham-company
First-light-asset-management
Goldman-sachs-group
Clinical-services
Neogenomics-company-profile
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.